Pre-hospital Administration of Thrombolytic Therapy With Urgent Culprit Artery Revascularization
Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The PATCAR study has been designed to test the hypothesis that the strategy of pre-hospital
use of a "clot busting" (thrombolytic) drug followed with emergent heart catheterization
including stenting of the problematic coronary artery, will result in a lower mortality and
reduced repeat heart attack rates.
Early identifying and treating heart attacks patients prior to the arriving at the hospital,
in those patients who qualify for the "clot busting" drugs will lower the size of the heart
attack damage. This smaller heart attack will lead to fewer problems with less repeat heart
attacks and death in the future.
Phase:
Phase 4
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston